Submissions for variant NM_001374504.1(TMPRSS6):c.1534G>A (p.Asp512Asn)

gnomAD frequency: 0.00006  dbSNP: rs137853120

Total submissions: 5

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Knight Diagnostic Laboratories, Oregon Health and Sciences University	RCV000001469	SCV001448910	likely pathogenic	Microcytic anemia	2017-06-01	criteria provided, single submitter	clinical testing
Fulgent Genetics, Fulgent Genetics	RCV001375845	SCV002792581	likely pathogenic	Iron-refractory iron deficiency anemia	2021-07-24	criteria provided, single submitter	clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard	RCV001375845	SCV003761254	likely pathogenic	Iron-refractory iron deficiency anemia	2023-01-25	criteria provided, single submitter	curation	The heterozygous p.Asp512Asn variant in TMPRSS6 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (hg38 chr22:g.37098319_37127846del), in one individual with iron-refractory iron deficiency anemia. This individual also carried a likely pathogenic variant (hg38 chr22:g.37098319_37127846del), however the phase of these variants are unknown at this time. The p.Asp512Asn variant in TMPRSS6 has been previously reported in 2 unrelated individuals with iron-refractory iron deficiency anemia (PMID: 19357398, PMID: 18408718) and segregated with disease in 2 affected individuals in one family (PMID: 18408718), but has been identified in 0.006% (8/129158) of non-Finnish European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs137853120). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 1404) and has been interpreted as pathogenic by OMIM and as likely pathogenic by Knight Diagnostic Laboratories, Oregon Health and Sciences University. Of the two unrelated individuals previously reported (PMID: 19357398, PMID: 18408718), one was a compound heterozygote that carried a reported pathogenic/likely pathogenic variant in trans (PMID: 18408718, ClinVar Variation ID: 1403) and the other was a compound heterozygote that carried a variant of uncertain significance in trans (PMID: 19357398, ClinVar Variation ID: 39759), which increases the likelihood that the p.Asp512Asn variant is pathogenic. The p.Asp512Asn variant is located in the LDLR domain, which may mediate interactions of the protein with macromolecules such as serine protease:inhibitor complexes and lipoproteins (PMID: 17981570), and multiple variants in the same region as p.Asp512Asn variant have been reported in association with disease in ClinVar (Variation ID: 30802, 1299579), suggesting that this variant is in a mutational hotspot and key functional domain and slightly supports pathogenicity. In vitro functional studies provide some evidence that the p.Asp512Asn variant may slightly impact protein function (PMID: 19357398). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive iron-refractory iron deficiency anemia. ACMG/AMP Criteria applied: PS3_Supporting, PM1_Supporting, PM2_Supporting, PM3, PP3 (Richards 2015).
OMIM	RCV001375845	SCV000021624	pathogenic	Iron-refractory iron deficiency anemia	2009-05-28	no assertion criteria provided	literature only
PreventionGenetics, part of Exact Sciences	RCV004755696	SCV005355704	pathogenic	TMPRSS6-related disorder	2024-08-01	no assertion criteria provided	clinical testing	The TMPRSS6 c.1561G>A variant is predicted to result in the amino acid substitution p.Asp521Asn. This variant has been reported in two compound heterozygous individuals with iron-refractory iron deficiency anemia (IRIDA) (Finberg et al. 2008. PubMed ID: 18408718; Silvestri et al. 2009. PubMed ID: 19357398). Functional studies have shown the c.1561G>A (p.Asp521Asn) variant to result in intracellular retention of the TMPRSS6 protein (Silvestri et al. 2009. PubMed ID: 19357398). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic.